BioSpace News Archive

TELA Bio, Inc. announced that the company will report third quarter 2022 financial results on Wednesday, November 9th, 2022.

Aurora Spine Corporation today announced positive interim results from a clinical study using the ZIP™ MIS Interspinous Fusion System.

iSpecimen Inc. announced that the Company has launched its new self-service Open Feasibilities Dashboard on iSpecimen Marketplace®, allowing supplier partners to review potential future research projects at any time and initiate their interest by submitting a proposal.

LEXEO Therapeutics (LEXEO), a clinical-stage biotech company advancing a pipeline of adeno-associated virus (AAV)-based gene therapy candidates for cardiovascular and central nervous system (CNS) diseases, today announced it will be presenting clinical and preclinical data at three upcoming scientific meetings.

Syneos Health® announced it is introducing a dedicated HUB Patient Suite combining the Company’s advisory, analytics and digitally-enabled capabilities to bring modern, prescription management services to Syneos Health Deployment Solutions customers.

Ocugen, Inc. today announced that it will host a conference call and live webcast to discuss the Company’s third quarter 2022 financial results and provide a business update at 8:30 a.m. ET on Tuesday, November 8, 2022.

HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a Phase II/III trial of fruquintinib in combination with sintilimab as second-line treatment for locally advanced or metastatic renal cell carcinoma (“RCC”) in China.

Endo International plc (OTC: ENDPQ) and the Sexual Medicine Society of North America (SMSNA) announced today the launch of a Peyronie’s Self-Assessment application, available now in the App Store and Google Play.

Better Therapeutics, Inc. announced today that Diane Gomez-Thinnes joined the company as Chief Commercial Officer.

Selecta Biosciences, Inc. (NASDAQ: SELB) today announced that it plans to host a conference call on Thursday, November 3, 2022, at 8:30 a.m. ET to discuss its financial results for the quarter ended September 30, 2022 and provide a business update.